OVERVIEW

Infectious Diseases Symposium 2024 is organized by Creighton University and will be held on Apr 27, 2024.

Description:
This conference will provide practitioners with the most recent advances and information to enhance knowledge, skills and performance in the treatment and diagnosis of infectious diseases.

Objectives:
Recognize patients labeled as “allergic to penicillin” who may indeed be candidates for receiving penicillin or related drugs.
Identify best practices in the antibiotic therapy for prosthetic joint infections, including oral vs parenteral therapy.
Limit treatment of asymptomatic bacteriuria to situations in which treatment is appropriate.
List and describe the common HIV tests and their indications.
List principal advantages and disadvantages of an injectable integrase inhibitor in the prevention and treatment of HIV.
Identify major changes in the 2024 immunization schedule affecting children.
Recognize situations other than HIV in which Pneumocystis carinii infection should be suspected.
Explain why the impact of dengue is changing.
Select appropriate laboratory tests for the diagnosis of suspected Clostridioides difficile infection.
Explain the role of new drug therapy options for Clostridioides difficile infection.

Additional details will be posted as soon as information is available.

KEY DATES

Event Start Date
27 Apr, 2024
Event Start Date
Event End Date
27 Apr, 2024
Event End Date

TARGET AUDIENCE

PhysicianPharmacistMedical TechnologistPublic Health ProfessionalsFellowsStudentsResidentsNurse Practitioners

SPECIALITIES

Internal Medicine PhysiciansNurse PractitionersPhysician Assistants

RELATED CONFERENCES & LIVE WEBINARS

Apr 04, 2022 - Nov 30, 2026 | Webcast

State required course for Alabama ...
6 AMA PRA Category 1 Credits™
...
More actions
US$246

May 16, 2022 - Nov 30, 2026 | Webcast

State required course for Arizona
40.25 AMA PRA Category 1 Credits™
...
More actions
US$740

Mar 28, 2022 - Nov 30, 2026 | Webcast

State required course for Washington
103.75 AMA PRA Category 1 Credits™
...
More actions
US$1,925.40